These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 76489)

  • 21. Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients.
    Filip DJ; Duquesnoy RJ; Aster RH
    Am J Hematol; 1976; 1(4):471-9. PubMed ID: 1008059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of allospecific granulocyte antigens by capillary agglutination and microgranulocytotoxicity.
    Thompson JS; Blaschke J; Birney S; Severson CD
    Transplant Proc; 1977 Dec; 9(4):1895-7. PubMed ID: 74887
    [No Abstract]   [Full Text] [Related]  

  • 23. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
    Freedman J; Gafni A; Garvey MB; Blanchette V
    Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of matched platelet transfusions from unrelated donors.
    Radvany R; Green D; Rossi EC; Draugelis AK; Kahan BD
    Transplant Proc; 1977 Mar; 9(1):513-7. PubMed ID: 867499
    [No Abstract]   [Full Text] [Related]  

  • 27. Importance of histocompatibility in platelet transfusion therapy.
    Yankee RA
    Vox Sang; 1971 May; 20(5):419-26. PubMed ID: 4106552
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies to private and public HLA class I epitopes in platelet recipients.
    Zimmermann R; Wittmann G; Zingsem J; Blasczyk R; Weisbach V; Eckstein R
    Transfusion; 1999 Jul; 39(7):772-80. PubMed ID: 10413287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA typing.
    Shaw JF
    Arch Pathol Lab Med; 1976 Jul; 100(7):341-5. PubMed ID: 59584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
    Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Formation of anti-leukocyte antibody and anti-platelet antibody and its effects on blood component transfusion].
    Shimoyama M; Minato K; Ideura Y; Kimura K
    Nihon Rinsho; 1977 Dec; 35(12):4146-54. PubMed ID: 342757
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of the HLA system.
    Perkins HA
    Am J Hematol; 1979; 6(3):285-92. PubMed ID: 384785
    [No Abstract]   [Full Text] [Related]  

  • 33. Microgranulocytotoxicity.
    Blaschke JW; Severson CD; Goeken NE; Thompson JS
    J Lab Clin Med; 1977 Aug; 90(2):249-58. PubMed ID: 69671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HL-A matching in thrombocyte and leukocyte transfusions.
    Matej H; Olearczyk J; Partyka T; Kotlarek-Haus S; Stawarz M; Dzierzkowa-Borodej W
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):181-7. PubMed ID: 807177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological aspects of platelet transfusions.
    Murphy MF; Waters AH
    Br J Haematol; 1985 Jul; 60(3):409-14. PubMed ID: 4015986
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates.
    McFarland JG; Anderson AJ; Slichter SJ
    Br J Haematol; 1989 Nov; 73(3):380-6. PubMed ID: 2605125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Status of data of HLA-typed donors for unrelated bone marrow transplantation in Hannover: organization and results].
    Müller R; Riedel T; Stangel W
    Beitr Infusionsther; 1990; 26():211-3. PubMed ID: 1703833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological characterization of human monocytes for HLA, B-lymphocyte, granulocyte, and monocyte-associated antigens by cytotoxicity testing.
    Drew SI; Nathanson DS; Zamfirescu P; Carter BM; Terasaki PI; Naiem F; Billing R
    Tissue Antigens; 1978 May; 11(5):385-93. PubMed ID: 308716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.